Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease

The protein Major Facilitator Superfamily Domain containing 2A (MFSD2a) was recently described as the primary carrier for docosahexaenoic acid (DHA) into the brain. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by lower DHA levels in blood lipids. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Campillo, María, Ruiz-Pastor, María José, Gázquez, Antonio, Marín-Muñoz, Juan, Noguera-Perea, Fuensanta, Ruiz-Alcaraz, Antonio J., Manzanares-Sánchez, Salvadora, Antúnez, Carmen, Larqué, Elvira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981746/
https://www.ncbi.nlm.nih.gov/pubmed/31861865
http://dx.doi.org/10.3390/ijms21010070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981746/
https://www.ncbi.nlm.nih.gov/pubmed/31861865
http://dx.doi.org/10.3390/ijms21010070

Ejemplares similares